Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.

Cytotherapy. 2010;12(1):50-9. Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial. Tarella C, Rutella S, Gualandi F, Melazzini M, Scimè R, Petrini M, Moglia C, Ulla M, Omedé P, Bella VL, Corbo M, Silani V, Siciliano G, Mora G, Caponnetto…

Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results.

BJU Int. 2008 Sep;102(8):976-80. doi: 10.1111/j.1464-410X.2008.07742.x. Epub 2008 May 28. Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: a feasibility study and the first clinical results. Zimmermann R1, Cumpanas A, Hoeltl L, Janetschek G, Stenzl A, Miclea F. Author information 1Department of Urology, Elisabethinen Hospital, Linz, Austria. reinhold.zimmermann@gmx.de Abstract OBJECTIVE: To investigate the feasibility…

Low-energy extracorporeal shock wave therapy for chronic pelvic pain syndrome: finally, the magic bullet?

Eur Urol. 2009 Sep;56(3):425-6. doi: 10.1016/j.eururo.2009.03.075. Epub 2009 Apr 3. Low-energy extracorporeal shock wave therapy for chronic pelvic pain syndrome: finally, the magic bullet? Marszalek M, Berger I, Madersbacher S. Comment on Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind, placebo-controlled study. [Eur Urol. 2009] Extracorporeal…

Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind placebo-controlled study.

Eur Urol. 2010 Mar;57(3):e24; author reply e25. doi: 10.1016/j.eururo.2009.10.017. Epub 2009 Oct 17. Re: Reinhold Zimmermann, Alin Cumpanas, Florin Miclea, Günter Janetschek. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind placebo-controlled study. Eur Urol 2009;56:418-24. Cai T, Bartoletti R. Comment on Extracorporeal shock wave therapy for…

Extracorporeal shock wave treatment for non-inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham-controlled study.

Chin Med J (Engl). 2012 Jan;125(1):114-8. Extracorporeal shock wave treatment for non-inflammatory chronic pelvic pain syndrome: a prospective, randomized and sham-controlled study. Zeng XY1, Liang C, Ye ZQ.   1Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China. Abstract BACKGROUND: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)…

Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial.

Efficacy of extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome: a randomized, controlled trial. Vahdatpour B1, Alizadeh F, Moayednia A, Emadi M, Khorami MH, Haghdani S. 1Department of Physical Medicine and Rehabilitation, Isfahan University of Medical Sciences, Isfahan, Iran. Abstract Objectives. To investigate the effectiveness of extracorporeal shock wave therapy (ESWT)…

A review of the potential to restore vision with stem cells.

Clin Exp Optom. 2008 Jan;91(1):78-84. A review of the potential to restore vision with stem cells. Mooney I, LaMotte J. Source Southern California College of Optometry, Fullerton, California 92831, USA. Abstract Vision research involving stem cells is a rapidly evolving field. Animal experiments have shown that in response to environmental cues, stem cells can repopulate damaged retinas,…

Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve.

Can J Ophthalmol. 2010 Aug;45(4):333-41. doi: 10.3129/i10-077. Current approaches and future prospects for stem cell rescue and regeneration of the retina and optic nerve. Dahlmann-Noor A, Vijay S, Jayaram H, Limb A, Khaw PT. Source UCL Partners AHSC, London, United Kingdom. Abstract The 3 most common causes of visual impairment and legal blindness in developed countries (age-related macular degeneration, glaucoma, and diabetic retinopathy) share 1 end point: the loss of neural cells of the eye.…

Genetic basis of inherited macular dystrophies and implications for stem cell therapy.

Stem Cells. 2009 Nov;27(11):2833-45. doi: 10.1002/stem.159. Genetic basis of inherited macular dystrophies and implications for stem cell therapy. Mellough CB, Steel DH, Lako M. Source Institute of Human Genetics, Newcastle University, International Centre for Life, Newcastle Upon Tyne NE1 3BZ, United Kingdom. Abstract Untreatable hereditary macular dystrophy (HMD) presents a major burden to society in terms of the resulting patient disability and the cost to the healthcare provision system. HMD results in…

Stemming vision loss with stem cells.

J Clin Invest. 2010 Sep;120(9):3012-21. doi: 10.1172/JCI42951. Epub 2010 Sep 1. Stemming vision loss with stem cells. Marchetti V, Krohne TU, Friedlander DF, Friedlander M. Source Department of Cell Biology, The Scripps Research Institute, La Jolla, California, USA. Abstract Dramatic advances in the field of stem cell research have raised the possibility of using these cells to treat a…